ANN SURG 润色咨询

ANNALS OF SURGERY

出版年份:1885 年文章数:6659 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:6.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2193940, encodeId=4d69219394031, content=审稿速度:2.0<br>偏重的研究方向:外科;肿瘤;临床研究<br>经验分享:投稿乳腺癌的人工智能临床研究,历程如下: 2023-5-12 submitted to journal 2023-5-13 with editor 2023-5-18 under review 2023-6-20 给了大修,给了三个月时间 2023-10-6 终于修回,因工作量大,延期修回了 2023-10-8 with editor 2023-10-25 under review 2023-11-20 required reviewers completed,当天转为with editor,过几天转为decision in process后一直状态不变 2024-2-12 终于变了revise,审稿人对回答均满意,提了新的语法及表述问题,给了一个半月 2024-2-27 修回 2024-2-28 with editor 2024-3-1 under review 2024-3-14 变成decision in process 2024-3-15 变成with editor 2024-3-17 又变成decision in process,同时发了接收函给通讯作者 总体感受:审稿人极其严谨,提的问题直击要害,很重视临床方面的讨论,修回工作量巨大,光返修信就去到150页,不愧是外科top期刊,对文章的要求贼高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Mon Mar 18 19:09:08 CST 2024, time=2024-03-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185200, encodeId=bd8d2185200d3, content=With editor 10天了,中间变过一次状态,啥意思啊?还有需要所有作者填写问卷吗?求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a38240897, createdName=ms7000001548641467, createdTime=Thu Feb 01 10:35:41 CST 2024, time=2024-02-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊,推荐转投吗?为什么没有直接告诉转投的期刊呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113744, encodeId=ffcf2113e4448, content=请问为什么它这个投稿页面这么卡,连注册都没法注册,应该不是网的问题,登录其他网站都可以,这是为啥呢?。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 09:17:33 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=886991, encodeId=aa08886991a0, content=Thank you for submitting your manuscript to Annals of Surgery.  Unfortunately, due to the many submissions we receive, we can accept less than 12% of our over 2800 manuscript submissions each year.  Many fine manuscripts are rejected because of the limited number of pages the publisher allow us.  Although your manuscript was not accepted by Annals, we would like you to consider the option of submitting your work to our companion journal, Annals of Surgery - Open:  Perspectives of Surgical History, Education and Clinical Approaches.  If you elect to submit to Annals of Surgery - Open,  we will give the paper full consideration for publication. The obvious advantage for you is a rapid turnover without needing to reinitiate the review process in a new journal. 这是啥意思?Aoso还算不算sci?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79401385523, createdName=songlingjun1230, createdTime=Mon Sep 21 07:12:25 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完,合著者必须要进行确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向:代谢<br>经验分享:请问下这个杂志可以催稿吗?"With Editor”10天了,一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888375, encodeId=42358883e51d, content=审稿速度:1.0<br>偏重的研究方向:结肠癌;液体活检;甲基化<br>经验分享:审稿一个月,没送外审直接拒稿,效率极差,不会再考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhRH6fwgzxM7UTajqVBeUOIsRDrQoPvCLLCicZ3A4tBpf06wEjdBSEXWkeH44Ce4vcDicCptnoX10A/132, createdBy=fd611636329, createdName=beijizhainan, createdTime=Fri Sep 25 19:44:24 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:with editor 30多天,没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584109, encodeId=3e305841097e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:以前尝试过一次Annals, 结果一个月内就悲剧了。2019年7月份,投稿的一篇国际多中心研究,非常惊喜的主编3天就给了小修,对研究肯定度很高,最后顺利接受发表。2019年9月另外一个病种的国际多中心研究,1个月审回,大修,1周修完,二审1个月,再次大修,2周修完;三审再大修,感觉要被拒的苗头,审稿人非常苛刻,揪住问题不放,最后惊险过关,艰难接收。。。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Sat Feb 01 19:19:00 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2024-03-18 只想躺平的小医生 来自广东省

    审稿速度:2.0
    偏重的研究方向:外科;肿瘤;临床研究
    经验分享:投稿乳腺癌的人工智能临床研究,历程如下: 2023-5-12 submitted to journal 2023-5-13 with editor 2023-5-18 under review 2023-6-20 给了大修,给了三个月时间 2023-10-6 终于修回,因工作量大,延期修回了 2023-10-8 with editor 2023-10-25 under review 2023-11-20 required reviewers completed,当天转为with editor,过几天转为decision in process后一直状态不变 2024-2-12 终于变了revise,审稿人对回答均满意,提了新的语法及表述问题,给了一个半月 2024-2-27 修回 2024-2-28 with editor 2024-3-1 under review 2024-3-14 变成decision in process 2024-3-15 变成with editor 2024-3-17 又变成decision in process,同时发了接收函给通讯作者 总体感受:审稿人极其严谨,提的问题直击要害,很重视临床方面的讨论,修回工作量巨大,光返修信就去到150页,不愧是外科top期刊,对文章的要求贼高

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2193940, encodeId=4d69219394031, content=审稿速度:2.0<br>偏重的研究方向:外科;肿瘤;临床研究<br>经验分享:投稿乳腺癌的人工智能临床研究,历程如下: 2023-5-12 submitted to journal 2023-5-13 with editor 2023-5-18 under review 2023-6-20 给了大修,给了三个月时间 2023-10-6 终于修回,因工作量大,延期修回了 2023-10-8 with editor 2023-10-25 under review 2023-11-20 required reviewers completed,当天转为with editor,过几天转为decision in process后一直状态不变 2024-2-12 终于变了revise,审稿人对回答均满意,提了新的语法及表述问题,给了一个半月 2024-2-27 修回 2024-2-28 with editor 2024-3-1 under review 2024-3-14 变成decision in process 2024-3-15 变成with editor 2024-3-17 又变成decision in process,同时发了接收函给通讯作者 总体感受:审稿人极其严谨,提的问题直击要害,很重视临床方面的讨论,修回工作量巨大,光返修信就去到150页,不愧是外科top期刊,对文章的要求贼高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Mon Mar 18 19:09:08 CST 2024, time=2024-03-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185200, encodeId=bd8d2185200d3, content=With editor 10天了,中间变过一次状态,啥意思啊?还有需要所有作者填写问卷吗?求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a38240897, createdName=ms7000001548641467, createdTime=Thu Feb 01 10:35:41 CST 2024, time=2024-02-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊,推荐转投吗?为什么没有直接告诉转投的期刊呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113744, encodeId=ffcf2113e4448, content=请问为什么它这个投稿页面这么卡,连注册都没法注册,应该不是网的问题,登录其他网站都可以,这是为啥呢?。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 09:17:33 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=886991, encodeId=aa08886991a0, content=Thank you for submitting your manuscript to Annals of Surgery.  Unfortunately, due to the many submissions we receive, we can accept less than 12% of our over 2800 manuscript submissions each year.  Many fine manuscripts are rejected because of the limited number of pages the publisher allow us.  Although your manuscript was not accepted by Annals, we would like you to consider the option of submitting your work to our companion journal, Annals of Surgery - Open:  Perspectives of Surgical History, Education and Clinical Approaches.  If you elect to submit to Annals of Surgery - Open,  we will give the paper full consideration for publication. The obvious advantage for you is a rapid turnover without needing to reinitiate the review process in a new journal. 这是啥意思?Aoso还算不算sci?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79401385523, createdName=songlingjun1230, createdTime=Mon Sep 21 07:12:25 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完,合著者必须要进行确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向:代谢<br>经验分享:请问下这个杂志可以催稿吗?"With Editor”10天了,一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888375, encodeId=42358883e51d, content=审稿速度:1.0<br>偏重的研究方向:结肠癌;液体活检;甲基化<br>经验分享:审稿一个月,没送外审直接拒稿,效率极差,不会再考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhRH6fwgzxM7UTajqVBeUOIsRDrQoPvCLLCicZ3A4tBpf06wEjdBSEXWkeH44Ce4vcDicCptnoX10A/132, createdBy=fd611636329, createdName=beijizhainan, createdTime=Fri Sep 25 19:44:24 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:with editor 30多天,没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584109, encodeId=3e305841097e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:以前尝试过一次Annals, 结果一个月内就悲剧了。2019年7月份,投稿的一篇国际多中心研究,非常惊喜的主编3天就给了小修,对研究肯定度很高,最后顺利接受发表。2019年9月另外一个病种的国际多中心研究,1个月审回,大修,1周修完,二审1个月,再次大修,2周修完;三审再大修,感觉要被拒的苗头,审稿人非常苛刻,揪住问题不放,最后惊险过关,艰难接收。。。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Sat Feb 01 19:19:00 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2024-02-01 ms7000001548641467 来自四川省

    With editor 10天了,中间变过一次状态,啥意思啊?还有需要所有作者填写问卷吗?求问

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2193940, encodeId=4d69219394031, content=审稿速度:2.0<br>偏重的研究方向:外科;肿瘤;临床研究<br>经验分享:投稿乳腺癌的人工智能临床研究,历程如下: 2023-5-12 submitted to journal 2023-5-13 with editor 2023-5-18 under review 2023-6-20 给了大修,给了三个月时间 2023-10-6 终于修回,因工作量大,延期修回了 2023-10-8 with editor 2023-10-25 under review 2023-11-20 required reviewers completed,当天转为with editor,过几天转为decision in process后一直状态不变 2024-2-12 终于变了revise,审稿人对回答均满意,提了新的语法及表述问题,给了一个半月 2024-2-27 修回 2024-2-28 with editor 2024-3-1 under review 2024-3-14 变成decision in process 2024-3-15 变成with editor 2024-3-17 又变成decision in process,同时发了接收函给通讯作者 总体感受:审稿人极其严谨,提的问题直击要害,很重视临床方面的讨论,修回工作量巨大,光返修信就去到150页,不愧是外科top期刊,对文章的要求贼高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Mon Mar 18 19:09:08 CST 2024, time=2024-03-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185200, encodeId=bd8d2185200d3, content=With editor 10天了,中间变过一次状态,啥意思啊?还有需要所有作者填写问卷吗?求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a38240897, createdName=ms7000001548641467, createdTime=Thu Feb 01 10:35:41 CST 2024, time=2024-02-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊,推荐转投吗?为什么没有直接告诉转投的期刊呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113744, encodeId=ffcf2113e4448, content=请问为什么它这个投稿页面这么卡,连注册都没法注册,应该不是网的问题,登录其他网站都可以,这是为啥呢?。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 09:17:33 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=886991, encodeId=aa08886991a0, content=Thank you for submitting your manuscript to Annals of Surgery.  Unfortunately, due to the many submissions we receive, we can accept less than 12% of our over 2800 manuscript submissions each year.  Many fine manuscripts are rejected because of the limited number of pages the publisher allow us.  Although your manuscript was not accepted by Annals, we would like you to consider the option of submitting your work to our companion journal, Annals of Surgery - Open:  Perspectives of Surgical History, Education and Clinical Approaches.  If you elect to submit to Annals of Surgery - Open,  we will give the paper full consideration for publication. The obvious advantage for you is a rapid turnover without needing to reinitiate the review process in a new journal. 这是啥意思?Aoso还算不算sci?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79401385523, createdName=songlingjun1230, createdTime=Mon Sep 21 07:12:25 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完,合著者必须要进行确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向:代谢<br>经验分享:请问下这个杂志可以催稿吗?"With Editor”10天了,一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888375, encodeId=42358883e51d, content=审稿速度:1.0<br>偏重的研究方向:结肠癌;液体活检;甲基化<br>经验分享:审稿一个月,没送外审直接拒稿,效率极差,不会再考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhRH6fwgzxM7UTajqVBeUOIsRDrQoPvCLLCicZ3A4tBpf06wEjdBSEXWkeH44Ce4vcDicCptnoX10A/132, createdBy=fd611636329, createdName=beijizhainan, createdTime=Fri Sep 25 19:44:24 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:with editor 30多天,没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584109, encodeId=3e305841097e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:以前尝试过一次Annals, 结果一个月内就悲剧了。2019年7月份,投稿的一篇国际多中心研究,非常惊喜的主编3天就给了小修,对研究肯定度很高,最后顺利接受发表。2019年9月另外一个病种的国际多中心研究,1个月审回,大修,1周修完,二审1个月,再次大修,2周修完;三审再大修,感觉要被拒的苗头,审稿人非常苛刻,揪住问题不放,最后惊险过关,艰难接收。。。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Sat Feb 01 19:19:00 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2023-08-10 ms2000000275921382 来自上海

    请问有大佬投这个期刊,推荐转投吗?为什么没有直接告诉转投的期刊呢?

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2193940, encodeId=4d69219394031, content=审稿速度:2.0<br>偏重的研究方向:外科;肿瘤;临床研究<br>经验分享:投稿乳腺癌的人工智能临床研究,历程如下: 2023-5-12 submitted to journal 2023-5-13 with editor 2023-5-18 under review 2023-6-20 给了大修,给了三个月时间 2023-10-6 终于修回,因工作量大,延期修回了 2023-10-8 with editor 2023-10-25 under review 2023-11-20 required reviewers completed,当天转为with editor,过几天转为decision in process后一直状态不变 2024-2-12 终于变了revise,审稿人对回答均满意,提了新的语法及表述问题,给了一个半月 2024-2-27 修回 2024-2-28 with editor 2024-3-1 under review 2024-3-14 变成decision in process 2024-3-15 变成with editor 2024-3-17 又变成decision in process,同时发了接收函给通讯作者 总体感受:审稿人极其严谨,提的问题直击要害,很重视临床方面的讨论,修回工作量巨大,光返修信就去到150页,不愧是外科top期刊,对文章的要求贼高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Mon Mar 18 19:09:08 CST 2024, time=2024-03-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185200, encodeId=bd8d2185200d3, content=With editor 10天了,中间变过一次状态,啥意思啊?还有需要所有作者填写问卷吗?求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a38240897, createdName=ms7000001548641467, createdTime=Thu Feb 01 10:35:41 CST 2024, time=2024-02-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊,推荐转投吗?为什么没有直接告诉转投的期刊呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113744, encodeId=ffcf2113e4448, content=请问为什么它这个投稿页面这么卡,连注册都没法注册,应该不是网的问题,登录其他网站都可以,这是为啥呢?。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 09:17:33 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=886991, encodeId=aa08886991a0, content=Thank you for submitting your manuscript to Annals of Surgery.  Unfortunately, due to the many submissions we receive, we can accept less than 12% of our over 2800 manuscript submissions each year.  Many fine manuscripts are rejected because of the limited number of pages the publisher allow us.  Although your manuscript was not accepted by Annals, we would like you to consider the option of submitting your work to our companion journal, Annals of Surgery - Open:  Perspectives of Surgical History, Education and Clinical Approaches.  If you elect to submit to Annals of Surgery - Open,  we will give the paper full consideration for publication. The obvious advantage for you is a rapid turnover without needing to reinitiate the review process in a new journal. 这是啥意思?Aoso还算不算sci?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79401385523, createdName=songlingjun1230, createdTime=Mon Sep 21 07:12:25 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完,合著者必须要进行确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向:代谢<br>经验分享:请问下这个杂志可以催稿吗?"With Editor”10天了,一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888375, encodeId=42358883e51d, content=审稿速度:1.0<br>偏重的研究方向:结肠癌;液体活检;甲基化<br>经验分享:审稿一个月,没送外审直接拒稿,效率极差,不会再考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhRH6fwgzxM7UTajqVBeUOIsRDrQoPvCLLCicZ3A4tBpf06wEjdBSEXWkeH44Ce4vcDicCptnoX10A/132, createdBy=fd611636329, createdName=beijizhainan, createdTime=Fri Sep 25 19:44:24 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:with editor 30多天,没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584109, encodeId=3e305841097e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:以前尝试过一次Annals, 结果一个月内就悲剧了。2019年7月份,投稿的一篇国际多中心研究,非常惊喜的主编3天就给了小修,对研究肯定度很高,最后顺利接受发表。2019年9月另外一个病种的国际多中心研究,1个月审回,大修,1周修完,二审1个月,再次大修,2周修完;三审再大修,感觉要被拒的苗头,审稿人非常苛刻,揪住问题不放,最后惊险过关,艰难接收。。。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Sat Feb 01 19:19:00 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2023-02-09 做梦也想sci 来自山东省

    请问为什么它这个投稿页面这么卡,连注册都没法注册,应该不是网的问题,登录其他网站都可以,这是为啥呢?。。

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2193940, encodeId=4d69219394031, content=审稿速度:2.0<br>偏重的研究方向:外科;肿瘤;临床研究<br>经验分享:投稿乳腺癌的人工智能临床研究,历程如下: 2023-5-12 submitted to journal 2023-5-13 with editor 2023-5-18 under review 2023-6-20 给了大修,给了三个月时间 2023-10-6 终于修回,因工作量大,延期修回了 2023-10-8 with editor 2023-10-25 under review 2023-11-20 required reviewers completed,当天转为with editor,过几天转为decision in process后一直状态不变 2024-2-12 终于变了revise,审稿人对回答均满意,提了新的语法及表述问题,给了一个半月 2024-2-27 修回 2024-2-28 with editor 2024-3-1 under review 2024-3-14 变成decision in process 2024-3-15 变成with editor 2024-3-17 又变成decision in process,同时发了接收函给通讯作者 总体感受:审稿人极其严谨,提的问题直击要害,很重视临床方面的讨论,修回工作量巨大,光返修信就去到150页,不愧是外科top期刊,对文章的要求贼高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Mon Mar 18 19:09:08 CST 2024, time=2024-03-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185200, encodeId=bd8d2185200d3, content=With editor 10天了,中间变过一次状态,啥意思啊?还有需要所有作者填写问卷吗?求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a38240897, createdName=ms7000001548641467, createdTime=Thu Feb 01 10:35:41 CST 2024, time=2024-02-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊,推荐转投吗?为什么没有直接告诉转投的期刊呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113744, encodeId=ffcf2113e4448, content=请问为什么它这个投稿页面这么卡,连注册都没法注册,应该不是网的问题,登录其他网站都可以,这是为啥呢?。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 09:17:33 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=886991, encodeId=aa08886991a0, content=Thank you for submitting your manuscript to Annals of Surgery.  Unfortunately, due to the many submissions we receive, we can accept less than 12% of our over 2800 manuscript submissions each year.  Many fine manuscripts are rejected because of the limited number of pages the publisher allow us.  Although your manuscript was not accepted by Annals, we would like you to consider the option of submitting your work to our companion journal, Annals of Surgery - Open:  Perspectives of Surgical History, Education and Clinical Approaches.  If you elect to submit to Annals of Surgery - Open,  we will give the paper full consideration for publication. The obvious advantage for you is a rapid turnover without needing to reinitiate the review process in a new journal. 这是啥意思?Aoso还算不算sci?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79401385523, createdName=songlingjun1230, createdTime=Mon Sep 21 07:12:25 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完,合著者必须要进行确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向:代谢<br>经验分享:请问下这个杂志可以催稿吗?"With Editor”10天了,一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888375, encodeId=42358883e51d, content=审稿速度:1.0<br>偏重的研究方向:结肠癌;液体活检;甲基化<br>经验分享:审稿一个月,没送外审直接拒稿,效率极差,不会再考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhRH6fwgzxM7UTajqVBeUOIsRDrQoPvCLLCicZ3A4tBpf06wEjdBSEXWkeH44Ce4vcDicCptnoX10A/132, createdBy=fd611636329, createdName=beijizhainan, createdTime=Fri Sep 25 19:44:24 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:with editor 30多天,没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584109, encodeId=3e305841097e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:以前尝试过一次Annals, 结果一个月内就悲剧了。2019年7月份,投稿的一篇国际多中心研究,非常惊喜的主编3天就给了小修,对研究肯定度很高,最后顺利接受发表。2019年9月另外一个病种的国际多中心研究,1个月审回,大修,1周修完,二审1个月,再次大修,2周修完;三审再大修,感觉要被拒的苗头,审稿人非常苛刻,揪住问题不放,最后惊险过关,艰难接收。。。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Sat Feb 01 19:19:00 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2020-09-21 songlingjun1230

    Thank you for submitting your manuscript to Annals of Surgery.  Unfortunately, due to the many submissions we receive, we can accept less than 12% of our over 2800 manuscript submissions each year.  Many fine manuscripts are rejected because of the limited number of pages the publisher allow us.  Although your manuscript was not accepted by Annals, we would like you to consider the option of submitting your work to our companion journal, Annals of Surgery - Open:  Perspectives of Surgical History, Education and Clinical Approaches.  If you elect to submit to Annals of Surgery - Open,  we will give the paper full consideration for publication. The obvious advantage for you is a rapid turnover without needing to reinitiate the review process in a new journal. 这是啥意思?Aoso还算不算sci?

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2193940, encodeId=4d69219394031, content=审稿速度:2.0<br>偏重的研究方向:外科;肿瘤;临床研究<br>经验分享:投稿乳腺癌的人工智能临床研究,历程如下: 2023-5-12 submitted to journal 2023-5-13 with editor 2023-5-18 under review 2023-6-20 给了大修,给了三个月时间 2023-10-6 终于修回,因工作量大,延期修回了 2023-10-8 with editor 2023-10-25 under review 2023-11-20 required reviewers completed,当天转为with editor,过几天转为decision in process后一直状态不变 2024-2-12 终于变了revise,审稿人对回答均满意,提了新的语法及表述问题,给了一个半月 2024-2-27 修回 2024-2-28 with editor 2024-3-1 under review 2024-3-14 变成decision in process 2024-3-15 变成with editor 2024-3-17 又变成decision in process,同时发了接收函给通讯作者 总体感受:审稿人极其严谨,提的问题直击要害,很重视临床方面的讨论,修回工作量巨大,光返修信就去到150页,不愧是外科top期刊,对文章的要求贼高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Mon Mar 18 19:09:08 CST 2024, time=2024-03-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185200, encodeId=bd8d2185200d3, content=With editor 10天了,中间变过一次状态,啥意思啊?还有需要所有作者填写问卷吗?求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a38240897, createdName=ms7000001548641467, createdTime=Thu Feb 01 10:35:41 CST 2024, time=2024-02-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊,推荐转投吗?为什么没有直接告诉转投的期刊呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113744, encodeId=ffcf2113e4448, content=请问为什么它这个投稿页面这么卡,连注册都没法注册,应该不是网的问题,登录其他网站都可以,这是为啥呢?。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 09:17:33 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=886991, encodeId=aa08886991a0, content=Thank you for submitting your manuscript to Annals of Surgery.  Unfortunately, due to the many submissions we receive, we can accept less than 12% of our over 2800 manuscript submissions each year.  Many fine manuscripts are rejected because of the limited number of pages the publisher allow us.  Although your manuscript was not accepted by Annals, we would like you to consider the option of submitting your work to our companion journal, Annals of Surgery - Open:  Perspectives of Surgical History, Education and Clinical Approaches.  If you elect to submit to Annals of Surgery - Open,  we will give the paper full consideration for publication. The obvious advantage for you is a rapid turnover without needing to reinitiate the review process in a new journal. 这是啥意思?Aoso还算不算sci?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79401385523, createdName=songlingjun1230, createdTime=Mon Sep 21 07:12:25 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完,合著者必须要进行确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向:代谢<br>经验分享:请问下这个杂志可以催稿吗?"With Editor”10天了,一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888375, encodeId=42358883e51d, content=审稿速度:1.0<br>偏重的研究方向:结肠癌;液体活检;甲基化<br>经验分享:审稿一个月,没送外审直接拒稿,效率极差,不会再考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhRH6fwgzxM7UTajqVBeUOIsRDrQoPvCLLCicZ3A4tBpf06wEjdBSEXWkeH44Ce4vcDicCptnoX10A/132, createdBy=fd611636329, createdName=beijizhainan, createdTime=Fri Sep 25 19:44:24 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:with editor 30多天,没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584109, encodeId=3e305841097e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:以前尝试过一次Annals, 结果一个月内就悲剧了。2019年7月份,投稿的一篇国际多中心研究,非常惊喜的主编3天就给了小修,对研究肯定度很高,最后顺利接受发表。2019年9月另外一个病种的国际多中心研究,1个月审回,大修,1周修完,二审1个月,再次大修,2周修完;三审再大修,感觉要被拒的苗头,审稿人非常苛刻,揪住问题不放,最后惊险过关,艰难接收。。。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Sat Feb 01 19:19:00 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2023-02-09 做梦也想sci 来自山东省

    请问投稿提交完,合著者必须要进行确认吗?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2193940, encodeId=4d69219394031, content=审稿速度:2.0<br>偏重的研究方向:外科;肿瘤;临床研究<br>经验分享:投稿乳腺癌的人工智能临床研究,历程如下: 2023-5-12 submitted to journal 2023-5-13 with editor 2023-5-18 under review 2023-6-20 给了大修,给了三个月时间 2023-10-6 终于修回,因工作量大,延期修回了 2023-10-8 with editor 2023-10-25 under review 2023-11-20 required reviewers completed,当天转为with editor,过几天转为decision in process后一直状态不变 2024-2-12 终于变了revise,审稿人对回答均满意,提了新的语法及表述问题,给了一个半月 2024-2-27 修回 2024-2-28 with editor 2024-3-1 under review 2024-3-14 变成decision in process 2024-3-15 变成with editor 2024-3-17 又变成decision in process,同时发了接收函给通讯作者 总体感受:审稿人极其严谨,提的问题直击要害,很重视临床方面的讨论,修回工作量巨大,光返修信就去到150页,不愧是外科top期刊,对文章的要求贼高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Mon Mar 18 19:09:08 CST 2024, time=2024-03-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185200, encodeId=bd8d2185200d3, content=With editor 10天了,中间变过一次状态,啥意思啊?还有需要所有作者填写问卷吗?求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a38240897, createdName=ms7000001548641467, createdTime=Thu Feb 01 10:35:41 CST 2024, time=2024-02-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊,推荐转投吗?为什么没有直接告诉转投的期刊呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113744, encodeId=ffcf2113e4448, content=请问为什么它这个投稿页面这么卡,连注册都没法注册,应该不是网的问题,登录其他网站都可以,这是为啥呢?。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 09:17:33 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=886991, encodeId=aa08886991a0, content=Thank you for submitting your manuscript to Annals of Surgery.  Unfortunately, due to the many submissions we receive, we can accept less than 12% of our over 2800 manuscript submissions each year.  Many fine manuscripts are rejected because of the limited number of pages the publisher allow us.  Although your manuscript was not accepted by Annals, we would like you to consider the option of submitting your work to our companion journal, Annals of Surgery - Open:  Perspectives of Surgical History, Education and Clinical Approaches.  If you elect to submit to Annals of Surgery - Open,  we will give the paper full consideration for publication. The obvious advantage for you is a rapid turnover without needing to reinitiate the review process in a new journal. 这是啥意思?Aoso还算不算sci?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79401385523, createdName=songlingjun1230, createdTime=Mon Sep 21 07:12:25 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完,合著者必须要进行确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向:代谢<br>经验分享:请问下这个杂志可以催稿吗?"With Editor”10天了,一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888375, encodeId=42358883e51d, content=审稿速度:1.0<br>偏重的研究方向:结肠癌;液体活检;甲基化<br>经验分享:审稿一个月,没送外审直接拒稿,效率极差,不会再考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhRH6fwgzxM7UTajqVBeUOIsRDrQoPvCLLCicZ3A4tBpf06wEjdBSEXWkeH44Ce4vcDicCptnoX10A/132, createdBy=fd611636329, createdName=beijizhainan, createdTime=Fri Sep 25 19:44:24 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:with editor 30多天,没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584109, encodeId=3e305841097e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:以前尝试过一次Annals, 结果一个月内就悲剧了。2019年7月份,投稿的一篇国际多中心研究,非常惊喜的主编3天就给了小修,对研究肯定度很高,最后顺利接受发表。2019年9月另外一个病种的国际多中心研究,1个月审回,大修,1周修完,二审1个月,再次大修,2周修完;三审再大修,感觉要被拒的苗头,审稿人非常苛刻,揪住问题不放,最后惊险过关,艰难接收。。。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Sat Feb 01 19:19:00 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2022-10-19 ms9000000711726322

    偏重的研究方向:代谢
    经验分享:请问下这个杂志可以催稿吗?"With Editor”10天了,一点动静没有。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2193940, encodeId=4d69219394031, content=审稿速度:2.0<br>偏重的研究方向:外科;肿瘤;临床研究<br>经验分享:投稿乳腺癌的人工智能临床研究,历程如下: 2023-5-12 submitted to journal 2023-5-13 with editor 2023-5-18 under review 2023-6-20 给了大修,给了三个月时间 2023-10-6 终于修回,因工作量大,延期修回了 2023-10-8 with editor 2023-10-25 under review 2023-11-20 required reviewers completed,当天转为with editor,过几天转为decision in process后一直状态不变 2024-2-12 终于变了revise,审稿人对回答均满意,提了新的语法及表述问题,给了一个半月 2024-2-27 修回 2024-2-28 with editor 2024-3-1 under review 2024-3-14 变成decision in process 2024-3-15 变成with editor 2024-3-17 又变成decision in process,同时发了接收函给通讯作者 总体感受:审稿人极其严谨,提的问题直击要害,很重视临床方面的讨论,修回工作量巨大,光返修信就去到150页,不愧是外科top期刊,对文章的要求贼高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Mon Mar 18 19:09:08 CST 2024, time=2024-03-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185200, encodeId=bd8d2185200d3, content=With editor 10天了,中间变过一次状态,啥意思啊?还有需要所有作者填写问卷吗?求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a38240897, createdName=ms7000001548641467, createdTime=Thu Feb 01 10:35:41 CST 2024, time=2024-02-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊,推荐转投吗?为什么没有直接告诉转投的期刊呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113744, encodeId=ffcf2113e4448, content=请问为什么它这个投稿页面这么卡,连注册都没法注册,应该不是网的问题,登录其他网站都可以,这是为啥呢?。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 09:17:33 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=886991, encodeId=aa08886991a0, content=Thank you for submitting your manuscript to Annals of Surgery.  Unfortunately, due to the many submissions we receive, we can accept less than 12% of our over 2800 manuscript submissions each year.  Many fine manuscripts are rejected because of the limited number of pages the publisher allow us.  Although your manuscript was not accepted by Annals, we would like you to consider the option of submitting your work to our companion journal, Annals of Surgery - Open:  Perspectives of Surgical History, Education and Clinical Approaches.  If you elect to submit to Annals of Surgery - Open,  we will give the paper full consideration for publication. The obvious advantage for you is a rapid turnover without needing to reinitiate the review process in a new journal. 这是啥意思?Aoso还算不算sci?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79401385523, createdName=songlingjun1230, createdTime=Mon Sep 21 07:12:25 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完,合著者必须要进行确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向:代谢<br>经验分享:请问下这个杂志可以催稿吗?"With Editor”10天了,一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888375, encodeId=42358883e51d, content=审稿速度:1.0<br>偏重的研究方向:结肠癌;液体活检;甲基化<br>经验分享:审稿一个月,没送外审直接拒稿,效率极差,不会再考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhRH6fwgzxM7UTajqVBeUOIsRDrQoPvCLLCicZ3A4tBpf06wEjdBSEXWkeH44Ce4vcDicCptnoX10A/132, createdBy=fd611636329, createdName=beijizhainan, createdTime=Fri Sep 25 19:44:24 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:with editor 30多天,没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584109, encodeId=3e305841097e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:以前尝试过一次Annals, 结果一个月内就悲剧了。2019年7月份,投稿的一篇国际多中心研究,非常惊喜的主编3天就给了小修,对研究肯定度很高,最后顺利接受发表。2019年9月另外一个病种的国际多中心研究,1个月审回,大修,1周修完,二审1个月,再次大修,2周修完;三审再大修,感觉要被拒的苗头,审稿人非常苛刻,揪住问题不放,最后惊险过关,艰难接收。。。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Sat Feb 01 19:19:00 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2020-09-25 beijizhainan

    审稿速度:1.0
    偏重的研究方向:结肠癌;液体活检;甲基化
    经验分享:审稿一个月,没送外审直接拒稿,效率极差,不会再考虑这个杂志。

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2193940, encodeId=4d69219394031, content=审稿速度:2.0<br>偏重的研究方向:外科;肿瘤;临床研究<br>经验分享:投稿乳腺癌的人工智能临床研究,历程如下: 2023-5-12 submitted to journal 2023-5-13 with editor 2023-5-18 under review 2023-6-20 给了大修,给了三个月时间 2023-10-6 终于修回,因工作量大,延期修回了 2023-10-8 with editor 2023-10-25 under review 2023-11-20 required reviewers completed,当天转为with editor,过几天转为decision in process后一直状态不变 2024-2-12 终于变了revise,审稿人对回答均满意,提了新的语法及表述问题,给了一个半月 2024-2-27 修回 2024-2-28 with editor 2024-3-1 under review 2024-3-14 变成decision in process 2024-3-15 变成with editor 2024-3-17 又变成decision in process,同时发了接收函给通讯作者 总体感受:审稿人极其严谨,提的问题直击要害,很重视临床方面的讨论,修回工作量巨大,光返修信就去到150页,不愧是外科top期刊,对文章的要求贼高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Mon Mar 18 19:09:08 CST 2024, time=2024-03-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185200, encodeId=bd8d2185200d3, content=With editor 10天了,中间变过一次状态,啥意思啊?还有需要所有作者填写问卷吗?求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a38240897, createdName=ms7000001548641467, createdTime=Thu Feb 01 10:35:41 CST 2024, time=2024-02-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊,推荐转投吗?为什么没有直接告诉转投的期刊呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113744, encodeId=ffcf2113e4448, content=请问为什么它这个投稿页面这么卡,连注册都没法注册,应该不是网的问题,登录其他网站都可以,这是为啥呢?。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 09:17:33 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=886991, encodeId=aa08886991a0, content=Thank you for submitting your manuscript to Annals of Surgery.  Unfortunately, due to the many submissions we receive, we can accept less than 12% of our over 2800 manuscript submissions each year.  Many fine manuscripts are rejected because of the limited number of pages the publisher allow us.  Although your manuscript was not accepted by Annals, we would like you to consider the option of submitting your work to our companion journal, Annals of Surgery - Open:  Perspectives of Surgical History, Education and Clinical Approaches.  If you elect to submit to Annals of Surgery - Open,  we will give the paper full consideration for publication. The obvious advantage for you is a rapid turnover without needing to reinitiate the review process in a new journal. 这是啥意思?Aoso还算不算sci?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79401385523, createdName=songlingjun1230, createdTime=Mon Sep 21 07:12:25 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完,合著者必须要进行确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向:代谢<br>经验分享:请问下这个杂志可以催稿吗?"With Editor”10天了,一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888375, encodeId=42358883e51d, content=审稿速度:1.0<br>偏重的研究方向:结肠癌;液体活检;甲基化<br>经验分享:审稿一个月,没送外审直接拒稿,效率极差,不会再考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhRH6fwgzxM7UTajqVBeUOIsRDrQoPvCLLCicZ3A4tBpf06wEjdBSEXWkeH44Ce4vcDicCptnoX10A/132, createdBy=fd611636329, createdName=beijizhainan, createdTime=Fri Sep 25 19:44:24 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:with editor 30多天,没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584109, encodeId=3e305841097e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:以前尝试过一次Annals, 结果一个月内就悲剧了。2019年7月份,投稿的一篇国际多中心研究,非常惊喜的主编3天就给了小修,对研究肯定度很高,最后顺利接受发表。2019年9月另外一个病种的国际多中心研究,1个月审回,大修,1周修完,二审1个月,再次大修,2周修完;三审再大修,感觉要被拒的苗头,审稿人非常苛刻,揪住问题不放,最后惊险过关,艰难接收。。。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Sat Feb 01 19:19:00 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2022-02-11 oncoma

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:with editor 30多天,没送外审直接被拒。效率太低了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2193940, encodeId=4d69219394031, content=审稿速度:2.0<br>偏重的研究方向:外科;肿瘤;临床研究<br>经验分享:投稿乳腺癌的人工智能临床研究,历程如下: 2023-5-12 submitted to journal 2023-5-13 with editor 2023-5-18 under review 2023-6-20 给了大修,给了三个月时间 2023-10-6 终于修回,因工作量大,延期修回了 2023-10-8 with editor 2023-10-25 under review 2023-11-20 required reviewers completed,当天转为with editor,过几天转为decision in process后一直状态不变 2024-2-12 终于变了revise,审稿人对回答均满意,提了新的语法及表述问题,给了一个半月 2024-2-27 修回 2024-2-28 with editor 2024-3-1 under review 2024-3-14 变成decision in process 2024-3-15 变成with editor 2024-3-17 又变成decision in process,同时发了接收函给通讯作者 总体感受:审稿人极其严谨,提的问题直击要害,很重视临床方面的讨论,修回工作量巨大,光返修信就去到150页,不愧是外科top期刊,对文章的要求贼高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Mon Mar 18 19:09:08 CST 2024, time=2024-03-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185200, encodeId=bd8d2185200d3, content=With editor 10天了,中间变过一次状态,啥意思啊?还有需要所有作者填写问卷吗?求问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71a38240897, createdName=ms7000001548641467, createdTime=Thu Feb 01 10:35:41 CST 2024, time=2024-02-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊,推荐转投吗?为什么没有直接告诉转投的期刊呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113744, encodeId=ffcf2113e4448, content=请问为什么它这个投稿页面这么卡,连注册都没法注册,应该不是网的问题,登录其他网站都可以,这是为啥呢?。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 09:17:33 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=886991, encodeId=aa08886991a0, content=Thank you for submitting your manuscript to Annals of Surgery.  Unfortunately, due to the many submissions we receive, we can accept less than 12% of our over 2800 manuscript submissions each year.  Many fine manuscripts are rejected because of the limited number of pages the publisher allow us.  Although your manuscript was not accepted by Annals, we would like you to consider the option of submitting your work to our companion journal, Annals of Surgery - Open:  Perspectives of Surgical History, Education and Clinical Approaches.  If you elect to submit to Annals of Surgery - Open,  we will give the paper full consideration for publication. The obvious advantage for you is a rapid turnover without needing to reinitiate the review process in a new journal. 这是啥意思?Aoso还算不算sci?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79401385523, createdName=songlingjun1230, createdTime=Mon Sep 21 07:12:25 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完,合著者必须要进行确认吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向:代谢<br>经验分享:请问下这个杂志可以催稿吗?"With Editor”10天了,一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888375, encodeId=42358883e51d, content=审稿速度:1.0<br>偏重的研究方向:结肠癌;液体活检;甲基化<br>经验分享:审稿一个月,没送外审直接拒稿,效率极差,不会再考虑这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhRH6fwgzxM7UTajqVBeUOIsRDrQoPvCLLCicZ3A4tBpf06wEjdBSEXWkeH44Ce4vcDicCptnoX10A/132, createdBy=fd611636329, createdName=beijizhainan, createdTime=Fri Sep 25 19:44:24 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:with editor 30多天,没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584109, encodeId=3e305841097e, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:以前尝试过一次Annals, 结果一个月内就悲剧了。2019年7月份,投稿的一篇国际多中心研究,非常惊喜的主编3天就给了小修,对研究肯定度很高,最后顺利接受发表。2019年9月另外一个病种的国际多中心研究,1个月审回,大修,1周修完,二审1个月,再次大修,2周修完;三审再大修,感觉要被拒的苗头,审稿人非常苛刻,揪住问题不放,最后惊险过关,艰难接收。。。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0323095804, createdName=xfzhang125, createdTime=Sat Feb 01 19:19:00 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2020-02-01 xfzhang125

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享:以前尝试过一次Annals, 结果一个月内就悲剧了。2019年7月份,投稿的一篇国际多中心研究,非常惊喜的主编3天就给了小修,对研究肯定度很高,最后顺利接受发表。2019年9月另外一个病种的国际多中心研究,1个月审回,大修,1周修完,二审1个月,再次大修,2周修完;三审再大修,感觉要被拒的苗头,审稿人非常苛刻,揪住问题不放,最后惊险过关,艰难接收。。。

    2

    展开2条回复
共57条页码: 1/6页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分